Nicole Murphy - Feb 7, 2024 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Head of Pharm Ops and Tech
Signature
/s/ Wendell Taylor, attorney in fact for Nicole Murphy
Stock symbol
BIIB
Transactions as of
Feb 7, 2024
Transactions value $
-$153,311
Form type
4
Date filed
2/9/2024, 08:01 PM
Previous filing
Jan 31, 2024
Next filing
Feb 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIIB Common Stock Options Exercise $0 +2.1K +36.26% $0.00 7.89K Feb 8, 2024 Direct
transaction BIIB Common Stock Tax liability -$153K -638 -8.08% $240.30 7.26K Feb 8, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Award $0 +5.82K $0.00 5.82K Feb 7, 2024 Common Stock 5.82K $0.00 Direct F1
transaction BIIB Restricted Stock Unit Options Exercise $0 -2.1K -33.32% $0.00 4.2K Feb 8, 2024 Common Stock 2.1K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024.
F2 The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/8/2023.